Internet CBT Eases Depressive Symptoms in Multiple Sclerosis

TOPLINE: An internet-based cognitive behavioral therapy (iCBT) program significantly reduced depressive symptoms in individuals with multiple sclerosis (MS) compared with care as usual, results from a multisite, phase 3, randomized trial show. METHODOLOGY: Between May 2017 and November 2020, investigators enrolled 279 participants in a randomized, controlled, phase 3 trial at five sites within the United States and Germany to […]

» Read more

Q&A: How social isolation, loneliness can shorten your life

Loneliness and social isolation are on the rise in the U.S., but as we take steps to find remedies, a new study reminds us that the two are separate problems, often linked (sometimes in surprising ways) but not always, and have different potential impacts. Being socially isolated carries much greater physical health risks but loneliness has a larger impact on […]

» Read more

Discrimination is the biggest career obstacle for women of color in the NHS—new research

In March 2023, NHS midwife Olukemi Akinmeji won an employment tribunal case against the hospital in Kent where, as an employee, she had faced race discrimination and victimization. That same month, Michelle Cox, a health care manager and senior nurse, won a case against NHS England and NHS Improvement Commissioning in Manchester. She too had faced racial discrimination. These cases […]

» Read more

Carol Stonham MBE, RN, MSc, Queen’s Nurse, and Policy Lead PCRS joins the Bedfont® Medical Advisory Board

Bedfont® Scientific Ltd, a leading innovator in breath analysis medical device technology, is proud to announce the addition of Carol Stonham, a highly respected and accredited respiratory healthcare expert, to its esteemed medical board. This appointment further strengthens Bedfont’s commitment to revolutionising respiratory healthcare solutions and delivering cutting-edge products to patients and healthcare professionals. ​​​​​​​ Image Credit: Bedfont Scientific Ltd. […]

» Read more

Short-Course SBRT: Standard of Care in Prostate Cancer?

SAN DIEGO — With just five fractions of stereotactic body radiation therapy (SBRT), men with low- or intermediate-risk prostate cancer can have 5-year disease control as good as that provided by conventional external-beam radiation therapy delivered at higher doses in 20-39 fractions, according to new data from the phase 3 randomized PACE-B trial. Overall, the 5-year event-free survival rates were […]

» Read more

Eli Lilly's head of diabetes and obesity unit to retire

Slideshow ( 2 images )(Reuters) -Eli Lilly and Co said on Wednesday that the head of its diabetes and obesity division, Mike Mason, will retire by the end of the year after more than three decades with the drugmaker. Mason oversaw the late-stage development of tirzepatide, Lilly’s potential blockbuster that is sold under the brand name Mounjaro for diabetes and […]

» Read more

Is ChatGPT ready to be your next medical advisor?

In a recent study published in JAMA Network Open, a team of researchers from Vanderbilt University examined the potential role of the Chat-Generative Pre-Trained Transformer (ChatGPT) in providing medical information to patients and health professionals. Study: Accuracy and Reliability of Chatbot Responses to Physician Questions. Image Credit: CkyBe / Shutterstock Background ChatGPT is widely used for various purposes nowadays. This large language model (LLM) […]

» Read more

Study addresses possible associations between chronic stress, mild cognitive impairment and Alzheimer's

Reviewed Researchers from Karolinska Institutet have published a study in Alzheimer's Research & Therapy that addresses possible associations between chronic stress, mild cognitive impairment and Alzheimer's disease. The study shows how people aged between 18 and 65 with a previous diagnosis of chronic stress and depression were more likely than other people to be diagnosed with mild cognitive impairment or […]

» Read more
1 39 40 41 42 43 1,330